- Home
- ENZ vs CLGN Comparison
ENZ vs CLGN Comparison
Compare ENZ & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENZ
- CLGN
- Stock Information
- Founded
- ENZ 1976
- CLGN 2004
- Country
- ENZ United States
- CLGN Israel
- Employees
- ENZ N/A
- CLGN N/A
- Industry
- ENZ Medical Specialities
- CLGN Industrial Specialties
- Sector
- ENZ Health Care
- CLGN Health Care
- Exchange
- ENZ Nasdaq
- CLGN Nasdaq
- Market Cap
- ENZ 34.2M
- CLGN 37.4M
- IPO Year
- ENZ N/A
- CLGN N/A
- Fundamental
- Price
- ENZ $0.31
- CLGN $2.42
- Analyst Decision
- ENZ
- CLGN Strong Buy
- Analyst Count
- ENZ 0
- CLGN 2
- Target Price
- ENZ N/A
- CLGN $12.50
- AVG Volume (30 Days)
- ENZ 625.0K
- CLGN 14.2K
- Earning Date
- ENZ 06-12-2025
- CLGN 05-28-2025
- Dividend Yield
- ENZ 31.59%
- CLGN N/A
- EPS Growth
- ENZ N/A
- CLGN N/A
- EPS
- ENZ N/A
- CLGN N/A
- Revenue
- ENZ $29,094,000.00
- CLGN $515,000.00
- Revenue This Year
- ENZ N/A
- CLGN $2,177.67
- Revenue Next Year
- ENZ N/A
- CLGN $56.52
- P/E Ratio
- ENZ N/A
- CLGN N/A
- Revenue Growth
- ENZ N/A
- CLGN N/A
- 52 Week Low
- ENZ $0.25
- CLGN $2.20
- 52 Week High
- ENZ $1.27
- CLGN $6.75
- Technical
- Relative Strength Index (RSI)
- ENZ 39.61
- CLGN 28.88
- Support Level
- ENZ $0.26
- CLGN $2.31
- Resistance Level
- ENZ $0.42
- CLGN $2.49
- Average True Range (ATR)
- ENZ 0.07
- CLGN 0.14
- MACD
- ENZ 0.01
- CLGN 0.02
- Stochastic Oscillator
- ENZ 35.29
- CLGN 30.94
About ENZ Enzo Biochem Inc. ($0.01 Par Value)
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.